Viewing Study NCT05644067


Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-01-06 @ 6:43 PM
Study NCT ID: NCT05644067
Status: COMPLETED
Last Update Posted: 2024-04-15
First Post: 2022-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country
Sponsor: Swiss Tropical & Public Health Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module